Literature DB >> 30119916

Long-Term Weight Loss and Metabolic Health in Adults Concerned With Maintaining or Losing Weight: Findings From NHANES.

Gregory Knell1, Qing Li2, Kelley Pettee Gabriel3, Kerem Shuval2.   

Abstract

More than two-thirds of American adults are overweight or obese, with many attempting to lose weight to avoid adverse health outcomes and improve well-being. Achieving long-term weight loss (LTWL) success, defined as reaching at least a 5% to 10% weight loss goal, is challenging, yet important for overall metabolic health. It is currently unclear whether achieving higher thresholds of LTWL is associated with improved health. Therefore, the purpose of this study was to examine the association between LTWL thresholds (5%-9.9%, 10%-14.9%, 15%-19.9%, ≥20%) and metabolic health (metabolic syndrome and metabolic risk z score) among 7670 US adult respondents to the National Health and Nutrition Examination Survey (2007-2014) who were overweight or obese (past or present), were not underweight in the past year, not pregnant, and attempting to lose or maintain weight. A subsample of 3362 participants was used in the analysis of the metabolic risk z score. Multivariable regression models were constructed adjusting for covariates. Results indicate that the lowest and the 2 highest LTWL thresholds were related to lower odds for metabolic syndrome; for example, greater than or equal to 20% LTWL (odds ratio=0.52; 95% CI, 0.23-0.44; P<.001). All LTWL thresholds were significantly associated with the metabolic risk z score, with the largest effect among the 2 highest LTWL thresholds, that is, 15% to 19.9% LTWL (β=-0.45; 95% CI, -0.54 to -0.36; P<.001) and greater than or equal to 20% LTWL (β=-0.35; 95% CI, -0.53 to -0.17; P<.001). In conclusion, although achieving the currently recommended LTWL target was related to improved metabolic health, the 15% LTWL threshold was associated with more favorable outcomes.
Copyright © 2018 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30119916      PMCID: PMC6526934          DOI: 10.1016/j.mayocp.2018.04.018

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  5 in total

1.  Goal-directed versus outcome-based financial incentives for weight loss among low-income patients with obesity: rationale and design of the Financial Incentives foR Weight Reduction (FIReWoRk) randomised controlled trial.

Authors:  Melanie Jay; Stephanie L Orstad; Soma Wali; Judith Wylie-Rosett; Chi-Hong Tseng; Victoria Sweat; Sandra Wittleder; Suzanne B Shu; Noah J Goldstein; Joseph A Ladapo
Journal:  BMJ Open       Date:  2019-04-08       Impact factor: 2.692

2.  Feasibility and efficacy of a novel technology-based approach to harness social networks for weight loss: the NETworks pilot randomized controlled trial.

Authors:  C M Monroe; M Geraci; C A Larsen; D S West
Journal:  Obes Sci Pract       Date:  2019-06-27

3.  Physical Activity, Sleep, and Sedentary Behavior among Successful Long-Term Weight Loss Maintainers: Findings from a U.S. National Study.

Authors:  Gregory Knell; Qing Li; Elisa Morales-Marroquin; Jeffrey Drope; Kelley Pettee Gabriel; Kerem Shuval
Journal:  Int J Environ Res Public Health       Date:  2021-05-22       Impact factor: 3.390

4.  Health & Wealth: is weight loss success related to monetary savings in U.S. adults of low-income? Findings from a National Study.

Authors:  Kerem Shuval; Bob M Fennis; Qing Li; Amir Grinstein; Meike Morren; Jeffrey Drope
Journal:  BMC Public Health       Date:  2019-11-21       Impact factor: 3.295

5.  Data integration for prediction of weight loss in randomized controlled dietary trials.

Authors:  Rikke Linnemann Nielsen; Marianne Helenius; Sara L Garcia; Henrik M Roager; Derya Aytan-Aktug; Lea Benedicte Skov Hansen; Mads Vendelbo Lind; Josef K Vogt; Marlene Danner Dalgaard; Martin I Bahl; Cecilia Bang Jensen; Rasa Muktupavela; Christina Warinner; Vincent Aaskov; Rikke Gøbel; Mette Kristensen; Hanne Frøkiær; Morten H Sparholt; Anders F Christensen; Henrik Vestergaard; Torben Hansen; Karsten Kristiansen; Susanne Brix; Thomas Nordahl Petersen; Lotte Lauritzen; Tine Rask Licht; Oluf Pedersen; Ramneek Gupta
Journal:  Sci Rep       Date:  2020-11-18       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.